The WOUNDCOM project was initially developed at Lund University and under Swedish law, all rights to the project belonged to the inventors who co-founded Colzyx. All the rights to present and future inventions related to the original invention have been transferred to the company. Colzyx filed a PCT application titled “Novel polypeptides and medical uses thereof” that became public in July 2017 (WO2017125585A3). The patenting process has entered the territories of Europe, US and China. Further patent applications have been filed in order to develop the intellectual property rights associated with molecules derived from human Collagen VI and the application of these.